Oriola Oyj (ORIOLA.HE) has a MoatMap StockRank of 55/100 based on Quality (32/100), Value (60/100), and Momentum (48/100) factor scores. The current signal is HOLD. Oriola is a Finnish pharmaceutical distributor and retailer. It operates in a low-margin, highly regulated environment with minimal pricing power, failing the Terry Smith quality compounder criteria.
Oriola Oyj is a leading pharmaceutical wholesale and distribution company operating in Finland and Sweden. The company's competitive moat is established through its critical infrastructure role, managing a significant share of pharmaceutical distribution to pharmacies and hospitals in its core markets. It operates as a highly defensive, low-margin utility-like business with a dominant market duopoly in the Nordics.
| Price | $1.07 |
| Market Cap | $201M |
| P/E (Forward) | 8.76 |
| Price/Book | 1.86 |
| Return on Equity | -21.1% |
| Return on Invested Capital | -15.2% |
| Debt/Equity | 78.88 |
| Gross Margin | 8.8% |
| Operating Margin | 4.0% |
| Revenue Growth | -2.2% |
| Dividend Yield | 10.7% |
| Free Cash Flow | $14M |
Oriola Oyj operates in the Pharmaceutical Retailers industry, part of the Healthcare sector (Finland).